Dianthus Therapeutics (DNTH) Misses Q1 EPS by 85c
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Join SI Premium – FREE
Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.85). Revenue for the quarter came in at $460 thousand.
For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
- Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c
- RenovoRx, Inc. (RNXT) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
